Scarica l'app Stockscreener
3.2751
2.53%
-0.0849
Precedente Chiudi:
$3.36
Aprire:
$3.35
Volume 24 ore:
763.95K
Relative Volume:
0.92
Capitalizzazione di mercato:
$1.21B
Reddito:
$159.54M
Utile/perdita netta:
$5.06M
Rapporto P/E:
-744.34
EPS:
-0.0044
Flusso di cassa netto:
$26.19M
1 W Prestazione:
-2.24%
1M Prestazione:
-0.75%
6M Prestazione:
+22.66%
1 anno Prestazione:
+34.23%
Intervallo 1D:
$3.265
$3.3579
Intervallo di 1 settimana:
$3.295
$3.41
Portata 52W:
$2.28
$3.6077
Cronos Group Inc Stock (CRON) Company Profile
Nome
Cronos Group Inc
Settore
Telefono
(416) 504-0004
Indirizzo
4491 CONCESSION RD 12, STAYNER, ON
Compare CRON vs TAK, TEVA, HLN, ZTS, UTHR
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
CRON
Cronos Group Inc
|
3.2751 | 1.21B | 159.54M | 5.06M | 26.19M | -0.0044 |
TAK
Takeda Pharmaceutical Co Adr
|
20.93 | 66.85B | 29.91B | 1.30B | 3.49B | 0.4056 |
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
41.55 | 48.46B | 17.53B | 1.58B | 444.18M | 1.3457 |
HLN
Haleon Plc Adr
|
8.685 | 38.19B | 14.54B | 2.22B | 2.58B | 0.4871 |
ZTS
Zoetis Inc
|
79.94 | 33.04B | 9.51B | 2.64B | 2.14B | 6.0361 |
UTHR
United Therapeutics Corp
|
602.27 | 25.83B | 3.17B | 1.29B | 1.01B | 27.09 |
Cronos Group Inc Stock (CRON) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2026-01-27 | Iniziato | Canaccord Genuity | Buy |
| 2022-11-02 | Iniziato | Bernstein | Mkt Perform |
| 2022-07-28 | Aggiornamento | Canaccord Genuity | Hold → Buy |
| 2022-05-11 | Aggiornamento | CIBC | Neutral → Sector Outperform |
| 2022-03-22 | Aggiornamento | Barclays | Underweight → Equal Weight |
| 2022-01-27 | Aggiornamento | Jefferies | Underperform → Hold |
| 2021-11-18 | Ripresa | BofA Securities | Underperform |
| 2021-04-28 | Ripresa | BofA Securities | Underperform |
| 2021-02-22 | Downgrade | CIBC | Sector Outperform → Neutral |
| 2020-06-24 | Aggiornamento | Raymond James | Mkt Perform → Outperform |
| 2020-04-27 | Downgrade | Raymond James | Outperform → Mkt Perform |
| 2020-04-14 | Downgrade | Piper Sandler | Overweight → Neutral |
| 2020-04-02 | Downgrade | BofA/Merrill | Buy → Neutral |
| 2020-03-31 | Downgrade | Canaccord Genuity | Hold → Sell |
| 2020-03-04 | Aggiornamento | MKM Partners | Neutral → Buy |
| 2020-03-03 | Downgrade | Stifel | Buy → Hold |
| 2019-10-18 | Aggiornamento | Stifel | Hold → Buy |
| 2019-09-20 | Iniziato | MKM Partners | Neutral |
| 2019-09-05 | Aggiornamento | BMO Capital Markets | Underperform → Market Perform |
| 2019-08-13 | Iniziato | Piper Jaffray | Overweight |
| 2019-08-09 | Aggiornamento | Canaccord Genuity | Sell → Hold |
| 2019-06-28 | Iniziato | Consumer Edge Research | Equal Weight |
| 2019-06-06 | Iniziato | Stifel | Hold |
| 2019-06-05 | Aggiornamento | BofA/Merrill | Underperform → Buy |
| 2019-04-17 | Iniziato | BofA/Merrill | Underperform |
| 2019-03-27 | Downgrade | Canaccord Genuity | Hold → Sell |
| 2019-02-25 | Iniziato | Jefferies | Underperform |
| 2019-01-18 | Iniziato | CIBC | Sector Outperform |
Mostra tutto
Cronos Group Inc Borsa (CRON) Ultime notizie
Why Is Cronos Group (NASDAQ:CRON) Drawing Attention Before Its Third Quarter Earnings Call? - Kalkine Media
Cronos (CRON) Upgraded to Strong Buy: Here's What You Should Know - Zacks Investment Research
Cronos Group (NASDAQ:CRON) shares in focus as cannabis stocks themes shift today - Kalkine Media
Form 4 Cronos Group Inc.: Christopher Martens (General Manager) For: 16 October - Investing.com Nigeria
Form 4 Cronos Group Inc.: Christopher Martens (General Manager) For: 16 October - Investing.com UK
General manager gets 46,875 stock units at Cronos Group (CRON), vesting in three installments. - Stock Titan
CGC Stock Price, Quote & News - Syfe
Aurora Cannabis Reaffirms Recommendation to Shareholders to Reject Curaleaf's Revised Hostile Bid - Cannabis Business Times
Cronos Completes Acquisition of CanAdelaar, Europe’s Largest Adult-Use Cannabis Company - GlobeNewswire Inc.
Can Spinach Gummies Lift Cronos Group (TSX:CRON) Cannabis Stock? - Kalkine Media
Daniel S Sullivan Stock Trades and Disclosures - TechGraph
Can Execution Reframe Cronos Group (NASDAQ:CRON)? - Kalkine Media
CRON Stock Rises 17% in Three Months: Time to Buy the Dip or Cash Out? - Zacks Investment Research
Cronos Group (NASDAQ:CRON) Rides Record Quarters and Israel Momentum - Kalkine Media
What Does the Dutch Deal Deadline Extension Mean for Cronos Group (NASDAQ:CRON)? - Kalkine Media
Aurora Maintains Shareholder Recommendation to Take No Action; Curaleaf Has Yet to File Revised Bid - Cannabis Business Times
Why is Cronos Group (NASDAQ:CRON) stock jumping on cannabis rescheduling buzz? - Kalkine Media
What's Behind Cronos Group's (NASDAQ:CRON) Big Moment in Cannabis Stocks Today? - Kalkine Media
Cronos Group (NASDAQ:CRON) Extends Dutch Acquisition Deadline as Cannabis Reform Talk Revives - Kalkine Media
Is Cronos Group (NASDAQ:CRON) the Cannabis Stocks Stock Everyone's Talking About? - Kalkine Media
Why Is Cronos Group (NASDAQ:CRON) Suddenly a Must-Watch Cannabis Stocks Stock Today? - Kalkine Media
What Did Cronos Group (NASDAQ:CRON) Share at Its First Strategy Day? - Kalkine Media
Cronos Group $10 Million Securities Class Action Settlement - Claim Depot
Can Cronos Group (NASDAQ:CRON) Sustain Its Record Revenue Streak? - Kalkine Media
Labaton Keller Sucharow LLP Announces a Proposed Settlement in the Cronos U.S. Securities Settlement - Yahoo! Finance Canada
Labaton Keller Sucharow LLP Announces a Proposed Settlement in the Cronos U.S. Securities Settlement - ca.finance.yahoo.com
Why is Cronos Group (NASDAQ:CRON) in focus amid today’s cannabis stocks discussion? - Kalkine Media
Is Cronos Group (NASDAQ:CRON) Stock Worth Watching Today? - Kalkine Media
2 Cannabis Stocks That Are Quietly Trouncing the Market in 2026 - The Motley Fool
Cronos Group’s CAD 1.13 Billion Liquidity Position Strengthens Financial Flexibility as Global Cannabis Expansion Accelerates - kalkine.ca
Cronos Group Inc. (NASDAQ:CRON) Given Average Rating of "Hold" by Brokerages - MarketBeat
Cronos Group Extends Long Stop Date To October 15 For Canadelaar BV DealSEC Filing - TradingView
Cronos Group Inc. (TSX:CRON) Advances as Cannabis Brand Growth and International Expansion Strengthen Investor Outlook - kalkine.ca
Why is Cronos Group (NASDAQ:CRON) stock in focus today? - Kalkine Media
Cronos Group (NASDAQ:CRON): What's Moving During A Choppy Session? - Kalkine Media
Cronos Group (TSX:CRON) Gains Attention Amid Cannabis Sector Shifts - Kalkine Media
Can Cronos Group (TSX:CRON) Sustain Its Growth Momentum? - Kalkine Media
Cronos Group Inc. stock falls Tuesday, underperforms market - MarketWatch
Could Cronos Group Inc. (TSX:CRON) Drive Cannabis Stock Interest? - Kalkine Media
Cronos Group Inc (TSX:CRON): Why Cannabis Market Trends Matter? - Kalkine Media
Cronos Group (NASDAQ:CRON): Steady Growth Behind A Quiet Cannabis Name - Kalkine Media
Why Are These Canadian Penny Stocks Turning Heads? - Kalkine Media
Cronos Group Inc (CRON): Why This Canadian-Listed Stock Could Be One to Watch in September - kalkine.ca
Cronos Group (TSX:CRON): What's Really Driving Recent Stock Momentum? - Kalkine Media
Does Cronos Group's (TSX:CRON) New Launch Signal Growth? - Kalkine Media
Is Cronos Group’s (TSX:CRON) Live Resin Push a Turning Point for Its Brand Strategy? - simplywall.st
Is Cronos Group’s (TSX:CRON) Live Resin Push a Turning Point for Its Brand Strategy? - simplywall.st
CRON News | CRONOS GROUP INC (NASDAQ:CRON) - ChartMill
Cronos Group (NASDAQ:CRON): Is Today’s Move A Sector Signal? - Kalkine Media
Arbutus Biopharma Corp (ABUS) Peer Comparison – Compare with Others - Value Research
Cronos Group Inc Azioni (CRON) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Cronos Group Inc Azioni (CRON) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| Wagner Adam | See remarks |
May 12 '26 |
Option Exercise |
0.00 |
10,367 |
0 |
103,987 |
| Buggy Shannon | See Remarks |
May 12 '26 |
Option Exercise |
0.00 |
20,622 |
0 |
187,501 |
| Kenost Jared Matthew | See Remarks |
May 12 '26 |
Option Exercise |
0.00 |
9,412 |
0 |
46,675 |
| Weigensberg Arye | See Remarks |
May 10 '26 |
Option Exercise |
0.00 |
3,118 |
0 |
211,555 |
| Wagner Adam | See remarks |
May 10 '26 |
Option Exercise |
0.00 |
20,470 |
0 |
93,620 |
| Kenost Jared Matthew | See Remarks |
May 10 '26 |
Option Exercise |
0.00 |
12,649 |
0 |
39,141 |
| Shlimak Anna | See Remarks |
Mar 19 '26 |
Option Exercise |
0.00 |
28,429 |
0 |
368,362 |
| Doucet Terrence Gregory Joseph | See Remarks |
Mar 15 '26 |
Option Exercise |
0.00 |
23,897 |
0 |
117,466 |
| Weigensberg Arye | See Remarks |
Mar 15 '26 |
Option Exercise |
0.00 |
24,236 |
0 |
208,437 |
| GORENSTEIN MICHAEL RYAN | See remarks below |
Mar 15 '26 |
Option Exercise |
0.00 |
324,540 |
0 |
13,340,723 |
1.08%
5.90%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):